Clinical Trial

Efficacy of Taurolidine Containing Lock Solution for Prevention of Central Venous Catheter Infection in ICU Patients

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to assess effectiveness of a taurolidine based lock solution in preventing the infections of central venous catheter (CVC) in intensive care unit (ICU) cases.
Trial Details
NCT Number NCT07366372
Lead Sponsor Tanta University
Conditions Taurolidine, Lock Solution, Prevention, Central Venous Catheter Infection, Intensive Care Unit
Enrollment 120 participants
Start Date 2023-05-01
Primary Completion 2024-11-01 (estimated)
Study Completion 2024-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-26